A case of coexistence between JAK2V617F and BCR /ABL-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A case of coexistence between JAK2V617F and BCR /ABL

Published:2008-07 Issue:1 Volume:81 Page:75-76
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Pardini Simonetta,Fozza Claudio,Contini Salvatore,Rimini Elena,Ottaviani Emanuela,Amabile Marilina,Rosti Gianantonio,Longinotti Maurizio

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2008.01063.x/fullpdf

Reference5 articles.

1. Classification, Diagnosis and Management of Myeloproliferative Disorders in the JAK2V617F Era

2. JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome–negative CML, and megakaryocytic leukemia

3. Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis

4. Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation

5. Comparative Evaluation of ThreeJAK2V617FMutation Detection Methods

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination;Frontiers in Oncology;2024-01-12

2. Is very high platelet count always associated with essential thrombocythemia? An unusual presentation in a child;Laboratory Medicine;2023-06-23

3. JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response;Annals of Hematology;2023-03-22

4. Development of chronic myeloid leukemia in a patient previously diagnosed with a JAK2-positive myeloproliferative neoplasm;Clinical Chemistry and Laboratory Medicine (CCLM);2021-05-10

5. Co-existence of BCR-ABL and JAK2V617F mutation in resistant chronic myeloid leukemia in the imatinib era: Is there a correlation?;Journal of Oncology Pharmacy Practice;2021-02-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3